Stocks In News: ARVL, RCM, ICCM
2:36 pm Tuesday, November 08th, 2022
Arrival (NASDAQ:ARVL) just reported earnings for 2022 Q3. But investors have more pressing concerns regarding the electric van startup. The company has spent the year on a downward trajectory, but its recent performance has been worse than many of its peers. ARVL stock has plunged 40% in just the past month as bad news has piled up. This has led the Nasdaq to issue a delisting warning. Now, Arrival has warned investors that it may not have the necessary cash to keep its business going. Investors are on edge as the possibility of bankruptcy becomes increasingly real. News of this new threat has pushed ARVL stock down 30% for the day with no rebound in sight.
Some healthcare market investors are probably feeling ill today, as financial traders are dumping R1 RCM (NASDAQ:RCM) stock like there’s no tomorrow. What are they reacting to? For one, R1 RCM revealed a CEO succession plan today. The company also disclosed its third-quarter results, which included some less-than-ideal data points. Headquartered in Utah, R1 RCM provides health information services for hospitals and other healthcare service systems. Without a doubt, the company has had to deal with high inflation and tight economic conditions in 2022.
IceCure Medical (NASDAQ:ICCM) stock is taking off on Tuesday as investors react to an update for Medicare coverage of breast cancer patients. The big news investors need to know about is the Centers for Medicare & Medicaid Services assigning ProSense “CPT Category III code 0581T to ambulatory payment classification 5091, Level 1 Breast/Lymphatic Surgery and Related Procedures.”
